Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
|
|
CUMBERLAND PHARMACEUTICALS INC (CPIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/03/2023 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.71, valued at
$111.2
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 10/03/2023 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.72, valued at
$111.8
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 10/03/2023 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 280 shares
@ $2.03, valued at
$568.4
Small acquisition of 280 shares
@ $2.12, valued at
$593.6
Small acquisition of 280 shares
@ $2.14, valued at
$599.2
Small acquisition of 280 shares
@ $2.28, valued at
$638.4
Small acquisition of 280 shares
@ $2.29, valued at
$641.2
Small acquisition of 280 shares
@ $2.24, valued at
$627.2
Small acquisition of 280 shares
@ $2.07, valued at
$579.6
Small acquisition of 280 shares
@ $1.98, valued at
$554.4
Small acquisition of 280 shares
@ $1.96, valued at
$548.8
Small acquisition of 280 shares
@ $1.9, valued at
$532 |
|
| 10/03/2023 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.71, valued at
$111.2
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
8-K
| Other Events Interactive Data |
| 06/07/2023 |
8-K
| Other Events Interactive Data |
| 06/02/2023 |
8-K
| Changes in Registrant's Certifying Accountant Interactive Data |
| 05/24/2023 |
8-K
| Changes in Registrant's Certifying Accountant Interactive Data |
| 05/16/2023 |
8-K
| Other Events Interactive Data |
| 05/16/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 04/04/2023 |
8-K
| Other Events Interactive Data |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 03/21/2023 |
4
| JACOBS JOEY A (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Disposed of 5,000 shares
@ $2.75, valued at
$13.8k
|
|
| 03/21/2023 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 37,205 shares
@ $1.92, valued at
$71.4k
|
|
| 03/21/2023 |
4
| Herman James L (VP and Chief Compliance Office) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,280 shares
@ $1.92, valued at
$2.5k
|
|
| 03/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/15/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|
|
|